查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1643372

球囊瓣环成形器械的全球市场

Balloon Valvuloplasty Devices
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 277 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球球囊瓣环成形设备市场规模将达到 27 亿美元

2024 年全球气球瓣环成形设备市场规模估计为 23 亿美元，预计 2030 年将达到 27 亿美元，2024-2030 年分析期间的复合年增长率为 2.8%。主动脉瓣狭窄应用是报告中分析的细分市场之一，预计其复合年增长率为 2.4%，到分析期结束时将达到 17 亿美元。预计在分析期内，肺动脉狭窄应用领域的成长率将达到 3.4%。

美国市场规模估计为 6.237 亿美元，中国市场预计复合年增长率为 5.2%

预计 2024 年美国球囊瓣环成形术设备市场价值将达到 6.237 亿美元。中国是世界第二大经济体，预计到 2030 年市场规模将达到 5.22 亿美元，2024-2030 年分析期间的复合年增长率为 5.2%。其他值得注意的区域市场包括日本和加拿大，预计在分析期间的复合年增长率分别为 1.1% 和 2.1%。在欧洲，德国的复合年增长率预计为 1.5%。

全球球囊瓣环成形设备市场 - 主要趋势与驱动因素摘要

微创手术的进步如何促进其广泛应用？

人们对微创治疗的日益偏好极大地推动了对球囊瓣环成形设备的需求。这些装置广泛用于治疗主动脉瓣和二尖瓣狭窄等心臟瓣膜疾病，为开胸手术提供了一种侵入性较小的替代方法。球囊瓣环成形的微创特性意味着恢復时间更快、併发症风险更低、患者预后更好，因此成为医疗保健提供者和患者的首选。

在球囊瓣环成形设备中，改进的导管设计、增强的影像引导和精确的球囊尺寸等技术创新进一步促进了球囊瓣环成形的普及。这些进步使心臟科医生即使在复杂的情况下也能更精确地执行有效的程序。因此，随着心血管疾病发病率的不断上升以及对先进治疗方案的需求，对这些设备的需求预计将继续上升。

为什么心臟瓣膜病患病率的上升会成为市场驱动力？

心臟瓣膜疾病发生率不断上升，尤其是在老化人口中，是推动球囊瓣环成形设备市场成长的关键因素。随着世界各地预期寿命的增加，主动脉瓣狭窄和瓣膜闭锁不全等疾病变得越来越常见。这些情况通常需要及时的医疗干预，以防止心臟衰竭、中风和心臟麻痹等併发症。

球囊瓣环成形是一种有价值的治疗选择，特别是对于不适合进行手术瓣膜置换术的高风险患者。因此，世界各地的医疗机构都采用球囊瓣环成形来提供有效的治疗。此外，人们对瓣膜疾病早期诊断和治疗的认识不断提高，鼓励更多患者前往医疗机构就诊，从而促进球囊瓣环成形术设备市场的发展。

技术进步如何提高设备效率？

球囊瓣环成形设备的技术进步显着提高了其效率和安全性。製造商正专注于开发下一代设备，其特点是具有更高压球囊、更强的机动性以及与成像系统的兼容性更强。这些改进可以实现精确的放置和扩展，从而最大限度地降低损伤周围组织的风险。

此外，即时成像和导航系统等数位工具的整合正在彻底改变手术的精确度。这些工具可以帮助临床医生在手术过程中观察和引导仪器，确保获得最佳效果。此外，生物相容性聚合物和灵活设计等材料创新正在提高患者的舒适度并降低术后併发症的可能性。这些技术进步不仅提高了球囊瓣环成形的有效性，而且扩大了其对更广泛患者的适用性。

哪些因素推动了球囊瓣环成形设备市场的成长？

球囊瓣环成形术设备市场的成长受到多种因素的推动，例如心臟瓣膜疾病盛行率的增加、微创技术的进步以及设备效率的持续提高。世界人口老化和心血管疾病的增加迫切需要有效的治疗方案，其中气球瓣环成形是一种重要的治疗方法。

消费行为，尤其是对恢復时间短的微创手术的需求日益增长，正在塑造市场动态。先进的影像引导和改进的导管设计等技术创新透过改善程序结果进一步推动市场成长。此外，对医疗保健基础设施的投资增加以及对瓣膜疾病早期疗育益处的认识不断提高，正在推动其广泛应用。这些因素支撑了全球气球瓣环成形设备市场的强劲成长轨迹。

部分

应用（主动脉瓣狭窄应用、肺动脉狭窄应用）；最终用途（医院最终用途、门诊手术中心最终用途、心导管实验室最终用途）

受访公司范例（43家值得关注的公司）

  • B. Braun Interventional Systems, Inc.
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • BrosMed Medical Company Limited
  • Edwards Lifesciences Corporation
  • Getinge AB（Getinge Group）
  • Koninklijke Philips NV
  • Medtronic Plc
  • Stryker Corporation
  • Terumo Corporation

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章 市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲国家
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 竞赛

简介目录
Product Code: MCP29463

Global Balloon Valvuloplasty Devices Market to Reach US$2.7 Billion by 2030

The global market for Balloon Valvuloplasty Devices estimated at US$2.3 Billion in the year 2024, is expected to reach US$2.7 Billion by 2030, growing at a CAGR of 2.8% over the analysis period 2024-2030. Aortic Valve Stenosis Application, one of the segments analyzed in the report, is expected to record a 2.4% CAGR and reach US$1.7 Billion by the end of the analysis period. Growth in the Pulmonary Valve Stenosis Application segment is estimated at 3.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$623.7 Million While China is Forecast to Grow at 5.2% CAGR

The Balloon Valvuloplasty Devices market in the U.S. is estimated at US$623.7 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$522.0 Million by the year 2030 trailing a CAGR of 5.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.1% and 2.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.5% CAGR.

Global Balloon Valvuloplasty Devices Market - Key Trends & Drivers Summarized

How Are Advancements in Minimally Invasive Procedures Driving Adoption?

The growing preference for minimally invasive procedures is significantly propelling the demand for balloon valvuloplasty devices. These devices are widely used in the treatment of valvular heart diseases, such as aortic stenosis and mitral stenosis, offering a less invasive alternative to open-heart surgery. The minimally invasive nature of balloon valvuloplasty results in reduced recovery times, lower risk of complications, and improved patient outcomes, making it a preferred choice among healthcare providers and patients.

Technological innovations in balloon valvuloplasty devices, such as improved catheter designs, enhanced imaging guidance, and precise balloon sizing, are further contributing to their adoption. These advancements enable cardiologists to perform highly accurate and effective procedures, even in complex cases. As a result, the demand for these devices is expected to continue its upward trajectory, driven by the increasing prevalence of cardiovascular diseases and the need for advanced treatment options.

Why Is the Rising Prevalence of Valvular Heart Diseases a Key Market Driver?

The rising prevalence of valvular heart diseases, particularly among the aging population, is a critical factor driving the growth of the balloon valvuloplasty devices market. Conditions such as aortic stenosis and mitral regurgitation are becoming increasingly common as global life expectancy improves. These diseases often require timely medical intervention to prevent complications such as heart failure, stroke, or sudden cardiac arrest.

Balloon valvuloplasty is a valuable treatment option, especially for high-risk patients who are not candidates for surgical valve replacement. This has spurred healthcare facilities worldwide to adopt these devices, ensuring access to effective therapies. Additionally, increasing awareness about early diagnosis and treatment of valvular conditions is encouraging more patients to seek medical attention, thereby boosting the market for balloon valvuloplasty devices.

How Are Technological Advancements Improving Device Efficiency?

Technological advancements in balloon valvuloplasty devices are significantly enhancing their efficiency and safety. Manufacturers are focusing on developing next-generation devices with features such as high-pressure balloons, advanced steerability, and enhanced compatibility with imaging systems. These improvements enable precise placement and dilation, minimizing the risk of damage to surrounding tissues.

Moreover, the integration of digital tools, such as real-time imaging and navigation systems, is revolutionizing procedural accuracy. These tools allow clinicians to visualize and guide the device during the procedure, ensuring optimal outcomes. Additionally, innovations in materials, such as biocompatible polymers and flexible designs, are improving patient comfort and reducing the likelihood of post-procedure complications. These technological strides are not only enhancing the efficacy of balloon valvuloplasty but also expanding its application across a broader patient population.

What Factors Are Driving the Growth of the Balloon Valvuloplasty Devices Market?

The growth in the balloon valvuloplasty devices market is driven by several factors, including the increasing prevalence of valvular heart diseases, advancements in minimally invasive technologies, and ongoing improvements in device efficiency. The aging global population and the associated rise in cardiovascular conditions have created a pressing need for effective treatment options, making balloon valvuloplasty a critical intervention.

Consumer behavior, particularly the growing demand for minimally invasive procedures with shorter recovery times, is shaping market dynamics. Technological innovations, such as advanced imaging guidance and improved catheter designs, are further supporting market expansion by enhancing procedural outcomes. Additionally, increased investment in healthcare infrastructure and rising awareness about the benefits of early intervention in valvular diseases are driving adoption. These factors collectively underscore the robust growth trajectory of the global balloon valvuloplasty devices market.

SCOPE OF STUDY:

The report analyzes the Balloon Valvuloplasty Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Application (Aortic Valve Stenosis Application, Pulmonary Valve Stenosis Application); End-Use (Hospitals End-Use, Ambulatory Surgery Centers End-Use, Cardiac Catheterization Labs End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 43 Featured) -

  • B. Braun Interventional Systems, Inc.
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • BrosMed Medical Company Limited
  • Edwards Lifesciences Corporation
  • Getinge AB (Getinge Group)
  • Koninklijke Philips NV
  • Medtronic Plc
  • Stryker Corporation
  • Terumo Corporation

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Economic Frontiers: Trends, Trials & Transformations
    • Balloon Valvuloplasty Devices - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Valvular Heart Diseases Spurs Demand for Balloon Valvuloplasty Devices
    • Technological Advancements in Minimally Invasive Cardiac Procedures Strengthen Market Growth
    • Increasing Geriatric Population Expands Addressable Market for Balloon Valvuloplasty Solutions
    • Growing Adoption of Catheter-Based Interventions Drives Demand for Advanced Valvuloplasty Devices
    • Expanding Healthcare Infrastructure in Emerging Markets Propels Market Opportunities
    • Rising Awareness About Minimally Invasive Treatment Options Accelerates Adoption Rates
    • Integration of Imaging Technologies with Valvuloplasty Devices Enhances Procedural Accuracy
    • Government Initiatives and Funding for Cardiovascular Health Strengthen Market Demand
    • Increasing Availability of Reimbursement Policies Supports Market Expansion
    • Surge in Demand for Outpatient Procedures Fuels Growth in Ambulatory Surgical Centers
    • High Burden of Congenital Heart Defects Drives Demand for Pediatric Balloon Valvuloplasty Devices
    • Innovations in Balloon Materials and Coatings Improve Device Performance and Durability
    • Expanding Focus on Personalized and Patient-Centric Treatment Approaches Drives Demand
    • Challenges in Open-Heart Surgery Propel Shift Toward Less Invasive Procedures
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Balloon Valvuloplasty Devices Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Balloon Valvuloplasty Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Balloon Valvuloplasty Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Aortic Valve Stenosis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Aortic Valve Stenosis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Aortic Valve Stenosis Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Pulmonary Valve Stenosis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Pulmonary Valve Stenosis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Pulmonary Valve Stenosis Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Ambulatory Surgery Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Cardiac Catheterization Labs End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Cardiac Catheterization Labs End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Cardiac Catheterization Labs End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Balloon Valvuloplasty Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: USA 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 23: USA Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: USA 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: Canada 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: Canada 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • JAPAN
    • Balloon Valvuloplasty Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: Japan 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Japan 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • CHINA
    • Balloon Valvuloplasty Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: China 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 41: China Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: China 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • EUROPE
    • Balloon Valvuloplasty Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Balloon Valvuloplasty Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Europe 15-Year Perspective for Balloon Valvuloplasty Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • FRANCE
    • Balloon Valvuloplasty Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 53: France Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: France 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: France 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • GERMANY
    • Balloon Valvuloplasty Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Germany 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Germany 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Italy 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Italy 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Balloon Valvuloplasty Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 71: UK Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: UK 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: UK 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Spain 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Spain 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Russia 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Russia 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Rest of Europe 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Balloon Valvuloplasty Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Balloon Valvuloplasty Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Asia-Pacific 15-Year Perspective for Balloon Valvuloplasty Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Balloon Valvuloplasty Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Australia 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Australia 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • INDIA
    • Balloon Valvuloplasty Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 110: India Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: India 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 113: India Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: India 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: South Korea 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: South Korea 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Balloon Valvuloplasty Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Balloon Valvuloplasty Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Latin America 15-Year Perspective for Balloon Valvuloplasty Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Latin America 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Argentina 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Argentina 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Brazil 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Brazil 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Mexico 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Mexico 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Rest of Latin America 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Balloon Valvuloplasty Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Balloon Valvuloplasty Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Middle East 15-Year Perspective for Balloon Valvuloplasty Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Middle East 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Iran 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Iran 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Israel 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Israel 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Saudi Arabia 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: UAE 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: UAE 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Rest of Middle East 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030
  • AFRICA
    • Balloon Valvuloplasty Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Balloon Valvuloplasty Devices by Application - Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Africa 15-Year Perspective for Balloon Valvuloplasty Devices by Application - Percentage Breakdown of Value Sales for Aortic Valve Stenosis Application and Pulmonary Valve Stenosis Application for the Years 2015, 2025 & 2030
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Balloon Valvuloplasty Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Africa 15-Year Perspective for Balloon Valvuloplasty Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cardiac Catheterization Labs End-Use for the Years 2015, 2025 & 2030

IV. COMPETITION